New lesions detected by single nucleotide polymorphism array-based chromosomal analysis have important clinical impact in acute myeloid leukemia

98Citations
Citations of this article
57Readers
Mendeley users who have this article in their library.

Abstract

Purpose: Cytogenetics is the primary outcome predictor in acute myeloid leukemia (AML). Metaphase cytogenetics (MC) detects an abnormal karyotype in only half of patients with AML, however. Single nucleotide polymorphism arrays (SNP-A) can detect acquired somatic uniparental disomy (UPD) and other cryptic defects, even in samples deemed normal by MC. We hypothesized that SNP-A will improve detection of chromosomal defects in AML and that this would enhance the prognostic value of MC. Patients and Methods: We performed 250K and 6.0 SNP-A analyses on 140 patients with primary (p) and secondary (s) AML and correlated the results with clinical outcomes and Flt-3/nucleophosmin (NPM-1) status. Results: SNP-A is more sensitive than MC in detecting unbalanced lesions (pAML, 65% v 39%, P = .002; and sAML, 78% v 51%, P = .003). Acquired somatic UPD, not detectable by MC, was common in our AML cohort (29% in pAML and 35% in sAML). Patients with SNP-A lesions including acquired somatic UPD exhibited worse overall survival (OS) and event-free survival (EFS) in pAML with normal MC and in pAML/sAML with abnormal MC. SNP-A improved the predictive value of Flt-3 internal tandem duplication/NPM-1 status, with inferior survival seen in patients with additional SNP-A defects. Multivariate analyses confirmed the independent predictive value of SNP-A defects for OS (hazard ratio [HR] = 2.52; 95% CI, 1.29 to 5.22; P = .006) and EFS (HR = 1.72; 95% CI, 1.12 to 3.48; P = .04). Conclusion: SNP-A analysis allows enhanced detection of chromosomal abnormalities and provides important prognostic impact in AML. © 2009 by American Society of Clinical Oncology.

References Powered by Scopus

Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group

4974Citations
N/AReaders
Get full text

International scoring system for evaluating prognosis in myelodysplastic syndromes

4052Citations
N/AReaders
Get full text

The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 trial

2450Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma

452Citations
N/AReaders
Get full text

Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms

344Citations
N/AReaders
Get full text

Dynamics of clonal evolution in myelodysplastic syndromes

328Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Tiu, R. V., Gondek, L. P., O’Keefe, C. L., Huh, J., Sekeres, M. A., Elson, P., … Maciejewski, J. P. (2009). New lesions detected by single nucleotide polymorphism array-based chromosomal analysis have important clinical impact in acute myeloid leukemia. Journal of Clinical Oncology, 27(31), 5219–5226. https://doi.org/10.1200/JCO.2009.21.9840

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 19

46%

Professor / Associate Prof. 8

20%

Lecturer / Post doc 8

20%

Researcher 6

15%

Readers' Discipline

Tooltip

Medicine and Dentistry 19

42%

Agricultural and Biological Sciences 14

31%

Biochemistry, Genetics and Molecular Bi... 7

16%

Pharmacology, Toxicology and Pharmaceut... 5

11%

Save time finding and organizing research with Mendeley

Sign up for free